9th World Bispecific Summit

Memo

As the only event to focus exclusively on bispecifics, the World Bispecific Summit 2018 will offer a greater breadth and depth of technical content than any other conference.



This content will arm you with the insights required to tackle the most challenging developmental hurdles encountered when working with these therapeutics, as well as shining a light on novel applications of bispecifics.



Join your peers to discuss strategies to select and validate synergistic targets, understand the true potential of novel formats, streamline CMC and developability processes and maximize clinical performance.



View the full event guide to see agenda topics, 30+ speaker line-up, discounts and registration information - https://bit.ly/2r9Ku8i. Early booking and group discounts are available. Visit website for full TandCs.



URLs:

Brochure: https://go.evvnt.com/225887-0?pid=5569

Tickets: https://go.evvnt.com/225887-1?pid=5569

Booking: https://go.evvnt.com/225887-4?pid=5569



Time: 8:30 am to 5:00 pm



Prices:

Gold: Conference and 2 Workshops (Standard Rate): USD 3997.0,

Silver: Conference and 1 Workshop (Standard Rate): USD 2998.0,

Bronze: Conference Only (Standard Rate): USD 2399.0,

Workshops Individual (Standard Rate): USD 699.0



Speakers: David Poon, Zymeworks, John Desjariais, Xencor, Rakesh Dixit, MedImmune, Jijie Gu, AbbVie, John Haurum, F-Star, Ercole Rao, Sanofi, Eric Smith, Regeneron, Janine Schuurman, Genmab, Daniel Hofmann, BioNTech, Jonathan Davis, Bristol-Myers Squibb, Edward Berger, National Institutes of Health, John Blankenship, Novartis, Matthias Friedrich, Amgen, Andrea Hooper, Pfizer, Jonathan Lai, Albert Einstein College of Medicine, Robert Mabry, Cogen Therapeutics, Laura von Schantz, Alligator Bioscience



Venue Details: Wyndham Boston Beacon Hill, 5 Blossom Street, Boston, 02114, United States